{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:21:24Z","timestamp":1791055284989,"version":"4.1.0"},"reference-count":13,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>As obesity is increasing in prevalence and its associated morbidity and mortality are escalating worldwide, medications like tirzepatide are frequently used for weight loss benefits in patients without diabetes. Tirzepatide has rarely been associated with acute pancreatitis, but there are no reported cases of fulminant, necrotizing pancreatitis resulting in fatality. We present a case of fatal, fulminant, necrotizing pancreatitis in a 64-year-old low-risk female patient with recent tirzepatide initiation. Prior to starting this medication, a case-by-case risk benefit analysis should be performed for each patient. The importance of this should be emphasized by making necrotizing pancreatitis a boxed warning for tirzepatide.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf087","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:08:13Z","timestamp":1745395693000},"source":"Crossref","is-referenced-by-count":4,"title":["Fatal, Fulminant, Necrotizing Pancreatitis Associated With Recent Tirzepatide Initiation"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7524-9917","authenticated-orcid":false,"given":"Krista","family":"Grennan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Borg","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Mayo Clinic , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Meneley","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Janitz","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Mayo Clinic , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midiia","family":"Shuman","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Mayo Clinic , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Venegas","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Mayo Clinic , Jacksonville, FL 32224 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"6","key":"2025042313221488600_luaf087-B1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2011.10.026","article-title":"Obesity and severe obesity forecasts through 2030","volume":"42","author":"Finkelstein","year":"2012","journal-title":"Am J Prev Med"},{"issue":"3","key":"2025042313221488600_luaf087-B2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"2025042313221488600_luaf087-B3","doi-asserted-by":"crossref","first-page":"bvad016","DOI":"10.1210\/jendso\/bvad016","article-title":"Adverse events related to tirzepatide","volume":"7","author":"Mishra","year":"2023","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025042313221488600_luaf087-B4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/dom.12833","article-title":"Use of incretin agents and risk of acute and chronic pancreatitis: a population-based cohort study","volume":"19","author":"Knapen","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2025042313221488600_luaf087-B5","first-page":"69","article-title":"Prognostic signs and the role of operative management in acute pancreatitis","volume":"139","author":"Ranson","year":"1974","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"2025042313221488600_luaf087-B6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.12669\/pjms.35.4.1286","article-title":"Accuracy of BISAP score in prediction of severe acute pancreatitis","volume":"35","author":"Arif","year":"2019","journal-title":"Pak J Med Sci"},{"key":"2025042313221488600_luaf087-B7","volume-title":"MOUNJARO (Tirzepatide) Injection, for Subcutaneous Use.","author":"Food and Drug Administration","year":"2022"},{"issue":"12","key":"2025042313221488600_luaf087-B8","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The Diabetes Prevention Program (DPP): description of lifestyle intervention","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group","year":"2002","journal-title":"Diabetes Care"},{"issue":"11","key":"2025042313221488600_luaf087-B9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2025042313221488600_luaf087-B10","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1210\/clinem\/dgab091","article-title":"Long-term weight loss strategies for obesity","volume":"106","author":"Kheniser","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2025042313221488600_luaf087-B11","doi-asserted-by":"crossref","first-page":"1214334","DOI":"10.3389\/fendo.2023.1214334","article-title":"Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2025042313221488600_luaf087-B12","doi-asserted-by":"crossref","first-page":"e70032","DOI":"10.1002\/osp4.70032","article-title":"Pancreatic safety of tirzepatide and its effects on islet cell function: a systematic review and meta-analysis","volume":"10","author":"Kamrul-Hasan","year":"2024","journal-title":"Obes Sci Pract"},{"issue":"4","key":"2025042313221488600_luaf087-B13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/alcalc\/agad012","article-title":"Alcohol drinking patterns and risk of developing acute and chronic pancreatitis","volume":"58","author":"Becker","year":"2023","journal-title":"Alcohol Alcohol"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/6\/luaf087\/62989821\/luaf087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/6\/luaf087\/62989821\/luaf087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:22:22Z","timestamp":1745428942000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf087\/8118086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,4,18]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf087","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,18]]},"article-number":"luaf087"}}